Wills Eye
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wills Eye sits in the top decile of US sponsors by registered trial count (#338 of 15,742 sponsors by registered trial count).
Wills Eye: 59 sponsored US clinical trials, 2 recruiting.
Wills Eye sponsors 59 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 52 completed. 5 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Glaucoma, with 5 trials.
Top-decile sponsor footprint
Wills Eye ranks in the top decile of sponsors by registered trial count (#338 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
52 of 56 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
59 total, page 1 of 2
Caffeine Consumption in Glaucoma Patients and Healthy Subjects
NCT03675412
Novel Glaucoma Diagnostics
NCT00286637
A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR
NCT05660447
Evaluating Home Testing Devices for the Management of Glaucoma
NCT05325996
Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection.
NCT06130384
Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin
NCT04784234
visuALL Field Analyzer (vFA) Compared to Standard Humphrey Automated Perimetry
NCT03804684
Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment
NCT03365778
Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study
NCT03323164
Handheld Vibrator Versus Topical Eye Drops as Anesthesia for Intravitreal Injections
NCT03079713
Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration
NCT03034772
30g vs 33g Needle for Intravitreal Injections
NCT03038048
Patient Comfort Using Green vs. Yellow Pan Retinal Photocoagulation
NCT02995629
Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane
NCT02995746
Social Worker in an Eye-Care Service
NCT03304535
Using a Type of Blue Dye to Observe Bleb Function During Cataract Surgery
NCT02526706
Comparing Rates of Glaucoma in Professional Wind Versus Non-Wind Instrument Players
NCT02612571
Interest in Electronic Applications for Patients With Glaucoma
NCT02659709
Factors Influencing Patient Satisfaction in a Glaucoma Population
NCT02628327
27-gauge Vitrectomy Wound Integrity: a Prospective, Randomized Trial Comparing Angled Versus Straight Entry
NCT02836210
Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.
NCT02571972
A Proposed Intervention to Decrease Resident-Performed Cataract Surgery Cancellation
NCT02621840
Normative Database for Pattern Electroretinogram (PERG) and Flash Electroretinogram (FERG)
NCT02609204
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
NCT02390245
Comparison Study of Glaucoma Eye Care Follow-Up Adherence in a High Risk Population
NCT02347670
Does Using a Low Vision Aid Device Improve Quality of Life in Glaucoma Patients?
NCT02526680
How Safe and Effective is Micropulse Transscleral Cyclophotocoagulation in Patients With Uncontrolled Glaucoma?
NCT02627352
Eplerenone for the Treatment of Central Serous Chorioretinopathy
NCT01990677
Improving Follow-Up Adherence in a Primary Eye Care Setting
NCT02001129
Comparing the Effect of the Water Drinking Test on Intraocular Pressure
NCT02001155
Electric Stimulation of the Eye to Improve Vision After Trauma
NCT02019927
Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment.
NCT01860586
The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy
NCT01710332
Overcoming Barriers in Vision Care Utilization of African Americans With Diabetes
NCT01744132
Building a Database of Results From People Without Eye Problems
NCT02627339
Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration
NCT01653184
Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol
NCT01533376
Comparison of Gonioscopy With Cirrus and Visante
NCT01895686
How Has Glaucoma Affected Your Quality of Life?
NCT01476644
How Accurately Does the Diopsys Visual Evoked Potential (VEP) Vision Testing System Detect Glaucoma?
NCT02622178
Isotretinoin for Proliferative Vitreoretinopathy
NCT01445028
Confronting Unequal Eye Care in Pennsylvania
NCT01179555
Does Glaucoma Cause Loss of Brain Function?
NCT01303939
Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube
NCT01301378
Water Drinking Test in Patients With Occludable Angle
NCT02613533
Spaeth/Richman Contrast Sensitivity Test
NCT01300949
Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?
NCT00853905
Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?
NCT00853073
A Study of the Effectiveness of a Local Injection of Chemotherapy for Retinoblastoma
NCT00857519
How Similar Are Changes to the Surface of the Eye When Two Different Glaucoma Eye Drops Are Used?
NCT00798694
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 7 |
| Phase 4 | 5 |
Therapeutic Areas
What is open in the Wills Eye pipeline
2 recruiting of 59 indexed (3% open); 52 completed (88%).
Phase mix: 5 late (III/IV) vs 8 early (I/II) (early-phase heavy).
Top condition: Glaucoma (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wills Eye: open-pipeline peers nationwide
Peers matched on 59 registered trials and 3% open enrollment, not the therapeutic-area sidebar.
Wills Eye sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 59 trials (± recruiting share)
- Clinical Nutrition Research Center, Illinois Institute of Technology · 59 trials · 7% recruiting
- United States Army Research Institute of Environmental Medicine · 59 trials · 12% recruiting
- University of Georgia · 59 trials · 20% recruiting
- Henry M. Jackson Foundation for the Advancement of Military Medicine · 60 trials · 22% recruiting
Sponsors near 3% open enrollment (± trial volume)
- SCRI Development Innovations · 3% recruiting · 146 trials
- Biotronik · 3% recruiting · 30 trials
- Charles Drew University of Medicine and Science · 3% recruiting · 30 trials
- Kyntra Bio · 3% recruiting · 30 trials
Related
What to do with this Wills Eye page
59 registered trials is a research-attention snapshot, not an endorsement of Wills Eye or any single study.
- 2 of Wills Eye's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Glaucoma is the condition Wills Eye studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Glaucoma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Wills Eye pipeline card: 59 registered trials from official public datasets.Report a data error.